S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

AHRQ Launches $11.8 Million Competition to Tackle Healthcare Monopolies

With Americans shouldering $556.6 billion in out-of-pocket costs during 2024, the Agency for Healthcare Research and Quality is seeking a market-based escape from hospital consolidation. The federal agency has launched an $11.8 million challenge to fund research into regulatory and organizational reforms that prioritize patient choice and lower prices.

AHRQ Launches $11.8 Million Competition to Tackle Healthcare Monopolies
Photo: Bio & News

Market concentration has reached a tipping point, as recent data shows a lack of competition across much of the United States. A March 2026 KFF analysis revealed that one or two health systems currently dominate inpatient care in nearly half of all metropolitan areas. In 83% of these regions, a duopoly controls more than 75% of the market, effectively insulating providers from the pressure to lower costs or improve service quality.

AHRQ Director Roger D. Klein stated that the initiative aims to solicit practical, evidence-based strategies from researchers, academic institutions, and private teams to dismantle these barriers. The project is split into two funding rounds: $3 million earmarked for the initial phase and $8.8 million for the follow-up. Applications for the first stage must be submitted by October 26, 2026, with judges evaluating proposals based on their novelty, feasibility, and potential impact on the national healthcare landscape.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!